NuVasive, Inc. (NASDAQ:NUVA) headquartered in San Diego, will host a conference call for the investment community to discuss the 3Q20 earnings result on 29th October 2020 at 1:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.nuvasive.com
Earnings Expectation
NuVasive, Inc. is reporting third quarter financial results on Thursday 29th October 2020, after market close.
According to analysts surveyed by Thomson Reuters, NUVA is expected to report 3Q20 income of $ 0.24 per share from revenue of $ 256.68 million.
For the full year, analysts anticipate top line of $ 1024.65 million, while looking forward to income of $ 0.97 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,215.00 million ~ $ 1,238.00 million, where as bottomline are predicted in a range of $ 2.55 ~ $ 2.65 per share
Click Here For More Historical Outlooks Of NuVasive, Inc.
NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The companys principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics.
